STOCK TITAN
  1. Home
  2. News
  3. MOTS

Motus GI Holdings Inc - MOTS STOCK NEWS

Welcome to our dedicated news page for Motus GI Holdings (Ticker: MOTS), a resource for investors and traders seeking the latest updates and insights on Motus GI Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Motus GI Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Motus GI Holdings's position in the market.

News
Motus GI Receives FDA Clearance to Commercialize Pure-Vu EVS Gastro and Gen 4 Colon
Rhea-AI Summary
Motus GI receives FDA clearance for new Pure-Vu EVS Gastro and Gen 4 Colon system, opening opportunities in the Upper GI market and improving endoscopic outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.64%
Tags
clinical trial
-
News
Motus GI Submits Special 510(k) to FDA for Pure-Vu EVS Gen 4 Gastro and Colon
Rhea-AI Summary
Motus GI Holdings submits special 510(k) for market clearance of its Pure-Vu Gen 4 Gastro and Colon, targeting the Upper GI market and reducing cost-of-goods by 50%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.05%
Tags
none
-
News
Motus GI Amends Royalty Agreement
Rhea-AI Summary
Motus GI cancels royalty rights in exchange for common stock, eliminating $1.0M in contingent royalty obligations from balance sheet.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.46%
Tags
none
News
Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors
Rhea-AI Summary
Motus GI Holdings, Inc. announces the appointment of Scott Durbin to its Board of Directors. David Hochman and Darren Sherman have resigned from the Board due to time requirements of their roles at Orchestra BioMed Holdings, Inc. Scott Durbin's extensive experience in finance and clinical development is expected to bring value to Motus GI. The company aims to secure FDA clearance for its next generation system. Durbin's appointment and the focus on expanding Pure-Vu System's capabilities could positively impact stockholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.42%
Tags
management
-
News
Motus GI to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Rhea-AI Summary
Motus GI Holdings, Inc. to present at H.C. Wainwright 25th Annual Global Investment Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.2%
Tags
conferences
-
News
Motus GI Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Rhea-AI Summary
MOTUS GI Holdings, Inc. (NASDAQ: MOTS) reported financial results for Q2 2023 and corporate updates. They are on track to submit a special 510(k) for Pure-Vu Gen 4 Gastro and Colon to the FDA, with system wide approval in Banner Medical Hospital Network. The company aims to target strategic and financing alternatives to accelerate commercialization of the Pure-Vu System.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.33%
Tags
earnings
News
Motus GI Receives Approval from the Israeli Ministry of Health to Initiate Commercial Sales of its Pure-Vu® EVS System
Rhea-AI Summary
Motus GI receives approval to initiate commercial sales of Pure-Vu EVS System in Israel
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.87%
Tags
none
-
News
Motus GI Announces Purchase Agreement for the Pure-Vu System® from Banner Desert Medical Center
Rhea-AI Summary
Motus GI Holdings, Inc. (NASDAQ: MOTS) Implements Pure-Vu System at Banner Desert Medical Center to Improve GI Endoscopy Procedures
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.85%
Tags
none
-
News
Motus GI Announces Pure-Vu Gen 4 Gastro and Colon System Featured at 9th IECED Live Endoscopy Course 2023 at the Pentax Learning Center
Rhea-AI Summary
Motus GI announced that the Pure-Vu Gen 4 Gastro and Colon system was featured in a live case during an underwater large polyp resection in the colon at the 9th Ecuadorian Institute of Digestive Diseases (IECED) Live Endoscopy Course 2023. Over 1,000 physicians registered for the course. The Pure-Vu Gen 4 system will have a new mode called 'fluid only' to support the new use case of underwater endoscopic mucosal resection (UEMR).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.29%
Tags
none
News
Motus GI Announces Appointment of Ravit Ram as Chief Financial Officer
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.32%
Tags
management
Stock MOTS logo
Motus GI Holdings Inc

Nasdaq:MOTS

MOTS Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

MOTS Stock Data

1.37M
4.97M
1.12%
4.71%
0.45%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Fort Lauderdale

About MOTS

motus gi holdings, inc. (nasdaq: mots) is a medical technology company based in the u.s., with subsidiaries in the u.s. and israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. the company is focused on the development and commercialization of the pure-vu® system, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. the pure-vu® system is a 510(k) u.s. food and drug administration cleared medical device indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. the device integrates with standard colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. the pure-vu® system has received ce mark approval in europe.